Regulations.gov document
PSG_216993 - Draft Guidance on Quizartinib Dihydrochloride
Other · FDA-2007-D-0369 · posted Nov 21, 2024
Key facts
| Document ID | FDA-2007-D-0369-2066 |
|---|---|
| Title | PSG_216993 - Draft Guidance on Quizartinib Dihydrochloride |
| Document type | Other |
| Subtype | Guidance |
| Agency | FDA |
| Docket | FDA-2007-D-0369 |
| Posted | Nov 21, 2024 |
| Comment period opens | Nov 21, 2024 |
| Comments due | Jan 22, 2025 |
At a glance
- No Open for comment
- 100–999 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: